PPD, Inc.

NC 28412-6461

Tel: +910 251 0081
Fax: +910 762 5820

Print Email to a friend

The combination of mass spectrometry-based proteomics, peptidomics and metabolomics enables broad screening for biomarkers of all biochemical types and sizes. PPD profiles biological samples with a label-free analysis that yields sensitive, reproducible, and reliable differential quantification and has developed rapid and advanced proprietary sample preparation procedures and fractionation techniques.

Further Information:

Related news from our archive

PPD to Discover Biomarkers for PDL BioPharma
PPD's biomarker discovery sciences group will examine specified sample sets utilizing DeepLook™ analysis.

Falco Selects PPD to Investigate Role of Biomarkers
PPD will apply its integrated platform for proteomics, peptidomics and metabolomics to identify biomarkers.